[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.159.27. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Capitol Health Call
February 12, 2014

GAO: Spending Estimates for National Preparedness Needed From DHHS

JAMA. 2014;311(6):564. doi:10.1001/jama.2014.542

Following public health emergencies such as the 2001 anthrax attacks and the 2009 H1N1 influenza pandemic, which raised concerns about the nation’s vulnerability to new infectious diseases and chemical, biological, radiological, and nuclear threats, the Department of Health and Human Services (DHHS) has become a key agency marshaling development and procurement of countermeasures such as drugs, vaccines, and diagnostic medical devices. But a December 27 report by the Government Accountability Office (GAO) found that the DHHS has not made public any spending estimates for its medical countermeasure development or procurement priorities, which may discourage potential developers from creating such countermeasures (http://1.usa.gov/1ar1oOY).

First Page Preview View Large
First page PDF preview
First page PDF preview
×